Summary & Overview

CPT 0708T: Cancer Immunotherapy Preparation and Initial Intradermal Injection

CPT code 0708T represents the preparation and initial intradermal injection of a cancer immunotherapy product. This code captures both the onsite preparation of the agent and the initial administration into the dermis, making it relevant for oncology practices offering investigational or specialized immunotherapy services. Nationally, codes like 0708T matter because they delineate procedural work related to emerging cancer immunotherapies and support claims for specialized therapeutic administration.

Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how this procedure is classified, common billing modifiers associated with procedural services where applicable, and guidance on typical sites of service. The publication also outlines benchmarks and policy context relevant to billing and coverage for immunotherapy administration, along with clinical context describing the nature of intradermal initial injections.

The report provides concise benchmarks, documentation considerations, and a summary of payer coverage patterns and policy updates that affect reimbursement for procedural immunotherapy administration. Data not available in the input is noted where applicable, and the narrative focuses on national-level implications for billing, coding, and clinical workflow related to CPT code 0708T.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0708TCPTcancer immunotherapyintradermal injectiononcologyprocedure codingadministration

Billing Code Overview

CPT code 0708T describes a procedure in which the provider prepares a cancer immunotherapy and performs an initial intradermal injection. This service is a therapeutic intervention involving preparation and administration of an immunotherapy agent delivered into the skin.

Service type: Procedural administration of cancer immunotherapy with preparation and initial intradermal injection
Typical site of service: Ambulatory clinic or outpatient infusion/oncology treatment setting

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with a confirmed or suspected cutaneous melanoma or other skin malignancy enrolled in an investigational or FDA-approved cancer immunotherapy protocol that requires intradermal administration for immunologic testing or initial therapeutic priming. The clinical workflow begins with pre-procedure verification of diagnosis, review of prior treatments, informed consent specific to the immunotherapy agent and intradermal technique, and assessment for allergy or contraindications. On the day of service the provider (often a dermatologist, medical oncologist, or immunotherapy nurse under physician supervision) prepares the cancer immunotherapy product under aseptic conditions, documents lot numbers and expiration, and performs an initial intradermal injection at a specified anatomical site (commonly the forearm or upper arm). Post-injection observation for immediate local or systemic reaction is performed, with documentation of injection site, dose, preparation steps, and any immediate adverse events. Billing captures preparation and the initial intradermal injection using 0708T when the provider prepares the immunotherapy and performs the initial intradermal administration as described.

Coding Specifications

Modifier	Description	When to Use
`22`	Unusual procedural services	Use when work required is substantially greater than typical for due to complexity or complications documented in operative note.

Taxonomy Code	Specialty	Notes
207RC0000X	Dermatology	Dermatologists frequently perform intradermal testing and immunotherapy injections for cutaneous malignancies and related immunologic procedures.
207RH0000X	Medical Oncology	Medical oncologists direct cancer immunotherapy regimens and may perform or supervise intradermal administrations in clinical settings.
364S00000X	Nurse Practitioner	Nurse practitioners often prepare and administer therapies under supervision in outpatient oncology/dermatology clinics.
193200000X	Immunology	Immunologists may be involved for diagnostic immunotherapy protocols and interpretation of intradermal immune responses.
363L00000X	Physician Assistant	Physician assistants commonly assist with preparation and initial injections under physician oversight.

ICD-10 Code	Description	Clinical Relevance
`C43.9`	Malignant melanoma of skin, unspecified	Melanoma is a common indication for investigational or therapeutic cancer immunotherapies administered intradermally.
`C44.9`	Malignant neoplasm of skin, unspecified	Non-melanoma skin cancers may be managed with adjunctive or investigational immunotherapy requiring intradermal administration.
`C80.1`	Malignant (primary) neoplasm, unspecified	Used when a primary site is unspecified but systemic immunotherapy protocols include intradermal priming or testing.
`D04.9`	Carcinoma in situ of skin, unspecified	In situ lesions may be subject to immunotherapy protocols or diagnostic intradermal immune response testing.
`Z85.820`	Personal history of malignant melanoma of skin	Relevant for surveillance visits where intradermal immunotherapy or vaccine-based protocols are considered.
`T88.7XXA`	Unspecified adverse effect of drug or medicament, initial encounter	Used if an adverse reaction related to the immunotherapy occurs and requires separate coding for the encounter.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96401`	Oncology injection, single drug, subcutaneous or intramuscular; non-hormonal anti-neoplastic	May be reported when additional subcutaneous or intramuscular oncologic injections are given during the same encounter as intradermal immunotherapy preparation, depending on payer bundling rules.
`96402`	Oncology injection, single drug, subcutaneous or intramuscular; hormonal anti-neoplastic	Relevant when hormonal antineoplastic injections are administered in conjunction with intradermal immunotherapy as part of a treatment regimen.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Often used for non-oncology injections administered in the same visit; payers may require separate reporting when services are distinct from `0708T`.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity	Common E/M code for pre-procedure evaluation or follow-up related to the immunotherapy administration when separately billable.
`99070`	Supplies and materials (except for those usually included with the procedure)	Used when additional, non-routine supplies for preparation of the immunotherapy are provided and not included in `0708T` reimbursement.
`96360`	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	Included as an example of supportive services (e.g., IV fluids or medications) that might be provided in the same encounter; report only if distinct and documented.

OpenPayer